Literature DB >> 24507617

Spatiotemporal evolution of erythema migrans, the hallmark rash of Lyme disease.

Dhruv K Vig1, Charles W Wolgemuth2.   

Abstract

To elucidate pathogen-host interactions during early Lyme disease, we developed a mathematical model that explains the spatiotemporal dynamics of the characteristic first sign of the disease, a large (≥5-cm diameter) rash, known as an erythema migrans. The model predicts that the bacterial replication and dissemination rates are the primary factors controlling the speed that the rash spreads, whereas the rate that active macrophages are cleared from the dermis is the principle determinant of rash morphology. In addition, the model supports the clinical observations that antibiotic treatment quickly clears spirochetes from the dermis and that the rash appearance is not indicative of the efficacy of the treatment. The quantitative agreement between our results and clinical data suggest that this model could be used to develop more efficient drug treatments and may form a basis for modeling pathogen-host interactions in other emerging infectious diseases.
Copyright © 2014 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24507617      PMCID: PMC3944903          DOI: 10.1016/j.bpj.2013.12.017

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  28 in total

1.  Network analysis reveals cross-links of the immune pathways activated by bacteria and allergen.

Authors:  Colin Campbell; Juilee Thakar; Réka Albert
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2011-09-28

2.  Model for chemotaxis.

Authors:  E F Keller; L A Segel
Journal:  J Theor Biol       Date:  1971-02       Impact factor: 2.691

3.  Macrophage accumulation, division, maturation, and digestive and microbicidal capacities in tuberculous lesions. 3. The turnover of macrophages and its relation to their activation and antimicrobial immunity in primary BCG lesions and those of reinfection.

Authors:  A M Dannenberg; M Ando; K Shima
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

4.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

5.  Quantitative detection of Borrelia burgdorferi by real-time PCR.

Authors:  A Pahl; U Kühlbrandt; K Brune; M Röllinghoff; A Gessner
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  Treatment of erythema migrans with doxycycline for 10 days versus 15 days.

Authors:  Dasa Stupica; Lara Lusa; Eva Ruzić-Sabljić; Tjasa Cerar; Franc Strle
Journal:  Clin Infect Dis       Date:  2012-04-20       Impact factor: 9.079

Review 7.  Does this patient have erythema migrans?

Authors:  Carrie D Tibbles; Jonathan A Edlow
Journal:  JAMA       Date:  2007-06-20       Impact factor: 56.272

8.  Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin.

Authors:  B W Berger; R C Johnson; C Kodner; L Coleman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

9.  Rapid flow cytometric studies of Borrelia burgdorferi phagocytosis by human polymorphonuclear leukocytes.

Authors:  E Banfi; M Cinco; S Perticarari; G Presani
Journal:  J Appl Bacteriol       Date:  1989-07

10.  Population Dynamics of Borrelia burgdorferi in Lyme Disease.

Authors:  Sebastian C Binder; Arndt Telschow; Michael Meyer-Hermann
Journal:  Front Microbiol       Date:  2012-03-22       Impact factor: 5.640

View more
  7 in total

Review 1.  Flagellar motility of the pathogenic spirochetes.

Authors:  Charles W Wolgemuth
Journal:  Semin Cell Dev Biol       Date:  2015-10-17       Impact factor: 7.727

2.  Vancomycin Reduces Cell Wall Stiffness and Slows Swim Speed of the Lyme Disease Bacterium.

Authors:  Michael W Harman; Alex E Hamby; Ross Boltyanskiy; Alexia A Belperron; Linda K Bockenstedt; Holger Kress; Eric R Dufresne; Charles W Wolgemuth
Journal:  Biophys J       Date:  2017-02-28       Impact factor: 4.033

Review 3.  Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums.

Authors:  Vladimir V Bamm; Jordan T Ko; Iain L Mainprize; Victoria P Sanderson; Melanie K B Wills
Journal:  Pathogens       Date:  2019-12-16

4.  Lyme Disease in Humans.

Authors:  Justin D Radolf; Klemen Strle; Jacob E Lemieux; Franc Strle
Journal:  Curr Issues Mol Biol       Date:  2020-12-11       Impact factor: 2.081

5.  Host-specific functional compartmentalization within the oligopeptide transporter during the Borrelia burgdorferi enzootic cycle.

Authors:  Ashley M Groshong; Melissa A McLain; Justin D Radolf
Journal:  PLoS Pathog       Date:  2021-01-11       Impact factor: 6.823

6.  Traveling wave of inflammatory response to regulate the expansion or shrinkage of skin erythema.

Authors:  Maki Sudo; Koichi Fujimoto
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

7.  Acute lyme disease IgG N-linked glycans contrast the canonical inflammatory signature.

Authors:  Benjamin Samuel Haslund-Gourley; Stéphane Grauzam; Anand S Mehta; Brian Wigdahl; Mary Ann Comunale
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.